Disparate SARS-CoV-2 infection outcomes abound, but what makes SARS-CoV-2 bound for rebound?

Affiliations

• ¹ Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.
• ² Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill, NC, 27599, USA.
• ³ Rapidly Emerging Antiviral Drug Development Initiative, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.